Chiasma Inc (CHMA.OQ)
CHMA.OQ on NASDAQ Stock Exchange Global Select Market
3.64USD
10 Dec 2018
3.64USD
10 Dec 2018
Change (% chg)
$0.09 (+2.54%)
$0.09 (+2.54%)
Prev Close
$3.55
$3.55
Open
$3.53
$3.53
Day's High
$3.73
$3.73
Day's Low
$3.40
$3.40
Volume
4,683
4,683
Avg. Vol
20,610
20,610
52-wk High
$4.81
$4.81
52-wk Low
$1.20
$1.20
About
Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
No analyst recommendations are available for .
Overall
| Beta: | -- |
| Market Cap(Mil.): | $70.64 |
| Shares Outstanding(Mil.): | 24.36 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CHMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 31.13 | 33.63 |
| EPS (TTM): | -1.28 | -- | -- |
| ROI: | -34.47 | 15.55 | 15.02 |
| ROE: | -35.41 | 16.92 | 16.60 |
Earnings vs. 
Estimates